The U.N.-backed program to get vaccines to the neediest people in the world has again scaled back its target to ship doses this year, projecting about 1.4 billion doses will available through by the end of the year.
Gavi, the Vaccine Alliance, says the COVAX program that it runs has faced setbacks. Those include export restrictions from hard-hit India, a key producer of vaccines, as well as regulatory hurdles for some vaccine candidates and manufacturing troubles elsewhere.
Still, Gavi says COVAX deliveries are ramping up significantly and another 1.1 billion doses are expected to become available beyond the 330 million doses it has already delivered. Most of the 1.4 billion doses are destined for the poorest developing countries.
Gavi had originally projected 2 billion doses could be shipped through COVAX this year, then in July lowered that projection to about 1.8 billion. Rich countries and others with vaccine production capabilities like Russia and China have already shipped billions of doses to their people, and the World Health Organization has repeatedly insisted that poor countries and health care workers in some places need better access to help stop new variants from emerging.
A top pharmaceutical industry association on Tuesday projected 12 billion doses will be produced this year. However, WHO officials say many are not being shipped where they are needed most.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)